MedKoo Cat#: 524718 | Name: CI 951

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CI 951 is a novel dihydronaphthyridine Ca2+ antagonist, channel blocker. CI-951 may be a useful therapeutic agent for focal cerebral ischemia. It has potential as a cerebral vasodilator.

Chemical Structure

CI 951
CI 951
CAS#126661-07-2

Theoretical Analysis

MedKoo Cat#: 524718

Name: CI 951

CAS#: 126661-07-2

Chemical Formula: C22H23F3N2O3

Exact Mass: 420.1661

Molecular Weight: 420.42

Elemental Analysis: C, 62.85; H, 5.51; F, 13.56; N, 6.66; O, 11.42

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
CI 951; CI-951; CI951.
IUPAC/Chemical Name
1,6-Naphthyridine-3-carboxylic acid, 1,4-dihydro-2-methyl-5-(1-methylethoxy)-4-(2-(trifluoromethyl)phenyl)-, ethyl ester
InChi Key
XVXQOAYCEUDQTQ-SFHVURJKSA-N
InChi Code
InChI=1S/C22H23F3N2O3/c1-5-29-21(28)17-13(4)27-16-10-11-26-20(30-12(2)3)19(16)18(17)14-8-6-7-9-15(14)22(23,24)25/h6-12,18,27H,5H2,1-4H3/t18-/m0/s1
SMILES Code
N1C(=C([C@@H](c2c(nccc12)OC(C)C)c1c(cccc1)C(F)(F)F)C(=O)OCC)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 420.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Knight WA, Hart KW, Adeoye OM, Bonomo JB, Keegan SP, Ficker DM, Szaflarski JP, Privitera MD, Lindsell CJ. The incidence of seizures in patients undergoing therapeutic hypothermia after resuscitation from cardiac arrest. Epilepsy Res. 2013 Oct;106(3):396-402. doi: 10.1016/j.eplepsyres.2013.06.018. Epub 2013 Jul 29. PubMed PMID: 23906560; PubMed Central PMCID: PMC3961478. 2: Papadakaki M, Tzamalouka GS, Chatzifotiou S, Chliaoutakis J. Seeking for risk factors of Intimate Partner Violence (IPV) in a Greek national sample: the role of self-esteem. J Interpers Violence. 2009 May;24(5):732-50. doi: 10.1177/0886260508317181. Epub 2008 May 7. PubMed PMID: 18463309. 3: Koike K, Takayanagi I, Takiguchi S, Urita Y, Miyake N. Ca-blocking action of stereoisomers of CI-951, (+)-CI-951 (NC-1500) and (-)-CI-951 in the isolated muscle preparations. Gen Pharmacol. 1992 Mar;23(2):207-10. PubMed PMID: 1639233. 4: Pucilowski O, Rezvani AH, Janowsky DS. Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438. Psychopharmacology (Berl). 1992;107(2-3):447-52. PubMed PMID: 1615142. 5: Meyer FB, Anderson RE, Sundt TM Jr. The novel dihydronaphthyridine Ca2+ channel blocker CI-951 improves CBF, brain pHi, and EEG recovery in focal cerebral ischemia. J Cereb Blood Flow Metab. 1990 Jan;10(1):97-103. PubMed PMID: 2298840.